Bushra Ijaz

494 total citations
27 papers, 383 citations indexed

About

Bushra Ijaz is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Bushra Ijaz has authored 27 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 15 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Bushra Ijaz's work include Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Bushra Ijaz is often cited by papers focused on Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (11 papers) and Liver Disease Diagnosis and Treatment (8 papers). Bushra Ijaz collaborates with scholars based in Pakistan, United States and United Arab Emirates. Bushra Ijaz's co-authors include Sajida Hassan, Waqar Ahmad, Saba Khaliq, Shah Jahan, Sheikh Riazuddin, Sidra Rehman, Usman Ali Ashfaq, Sultan Asad, Syed Aun Muhammad and Nighat Fatima and has published in prestigious journals such as Biotechnology Advances, International Journal of Biological Macromolecules and Biomedicine & Pharmacotherapy.

In The Last Decade

Bushra Ijaz

27 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bushra Ijaz Pakistan 13 179 143 108 34 31 27 383
Satoshi Sobue Japan 12 85 0.5× 121 0.8× 98 0.9× 20 0.6× 22 0.7× 34 469
Muhammad Ashfaq–Khan Germany 6 238 1.3× 331 2.3× 166 1.5× 10 0.3× 40 1.3× 8 749
Humera Kausar Pakistan 12 160 0.9× 194 1.4× 181 1.7× 5 0.1× 24 0.8× 31 565
Iara Fabrícia Kretzer Brazil 10 45 0.3× 62 0.4× 97 0.9× 16 0.5× 17 0.5× 16 303
Yoshitaka Shirasago Japan 12 104 0.6× 104 0.7× 116 1.1× 5 0.1× 13 0.4× 21 360
Xue Zhou China 11 250 1.4× 305 2.1× 133 1.2× 33 1.0× 53 1.7× 14 513
Marika Kleman Sweden 10 199 1.1× 185 1.3× 256 2.4× 9 0.3× 38 1.2× 20 625
Mengyun Ke China 16 83 0.5× 113 0.8× 270 2.5× 7 0.2× 33 1.1× 32 697
Judy S. Mathew United States 10 80 0.4× 123 0.9× 220 2.0× 24 0.7× 11 0.4× 13 466
Joo‐Youn Lee South Korea 15 59 0.3× 117 0.8× 282 2.6× 3 0.1× 39 1.3× 66 638

Countries citing papers authored by Bushra Ijaz

Since Specialization
Citations

This map shows the geographic impact of Bushra Ijaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bushra Ijaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bushra Ijaz more than expected).

Fields of papers citing papers by Bushra Ijaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bushra Ijaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bushra Ijaz. The network helps show where Bushra Ijaz may publish in the future.

Co-authorship network of co-authors of Bushra Ijaz

This figure shows the co-authorship network connecting the top 25 collaborators of Bushra Ijaz. A scholar is included among the top collaborators of Bushra Ijaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bushra Ijaz. Bushra Ijaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sohail, Aamir, et al.. (2025). Antifibrotic potential of reserpine (alkaloid) targeting Keap1/Nrf2; oxidative stress pathway in CCl4-induced liver fibrosis. Chemico-Biological Interactions. 407. 111384–111384. 1 indexed citations
2.
Noreen, Sobia, Farooq Anwar, Bushra Ijaz, et al.. (2025). Terminalia arjuna gum as a novel biopolymer for microbead formulation in pH-sensitive drug delivery. Drug Development and Industrial Pharmacy. 51(10). 1299–1317. 1 indexed citations
3.
Ain, Qurrat Ul, Ayesha Malik, Imran Shahid, et al.. (2024). Exploring antiviral activity of Betanin and Glycine Betaine against dengue virus type-2 in transfected Hela cells. Microbial Pathogenesis. 195. 106894–106894. 1 indexed citations
4.
Ijaz, Bushra, et al.. (2022). ADIPOSE-DERIVED STEM CELLS (ADSCS) PRETREATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) PROMOTED WOUND HEALING IN RAT SKIN BURN MODEL. Biological and Clinical Sciences Research Journal. 2022(1). 1 indexed citations
5.
Tawab, Abdul, et al.. (2022). Flavonoid rich extract of Trigonella foenum-graecum leaves ameliorate liver fibrosis. Food Bioscience. 50. 102046–102046. 4 indexed citations
6.
Ishtiaq, Saiqa, et al.. (2021). In vitro phytochemical and anticancer activity of Misopates orontium L. and Dicliptera bupleuroides Nees.. Pakistan Journal of Pharmaceutical Sciences. 34(3(Special)). 1195–1202. 1 indexed citations
7.
Khalid, Hina, et al.. (2020). Discovery of novel Hepatitis C virus inhibitor targeting multiple allosteric sites of NS5B polymerase. Infection Genetics and Evolution. 84. 104371–104371. 18 indexed citations
8.
9.
Noreen, Sobia, et al.. (2019). Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery. International Journal of Biological Macromolecules. 152. 1056–1067. 39 indexed citations
10.
Rehman, Sidra, Usman Ali Ashfaq, Bushra Ijaz, & Sheikh Riazuddin. (2018). Anti-hepatitis C virus activity and synergistic effect of Nymphaea alba extracts and bioactive constituents in liver infected cells. Microbial Pathogenesis. 121. 198–209. 20 indexed citations
11.
Kausar, Humera, Waqar Ahmad, Sana Javaid Awan, et al.. (2017). Role of alternative phosphorylation and O-glycosylation of erythropoietinreceptor in modulating its function: an in silico study. TURKISH JOURNAL OF BIOLOGY. 41. 816–825. 1 indexed citations
12.
Rehman, Sidra, Bushra Ijaz, Nighat Fatima, Syed Aun Muhammad, & Sheikh Riazuddin. (2016). Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study. Biomedicine & Pharmacotherapy. 83. 881–891. 46 indexed citations
13.
Shahid, Imran, Bushra Ijaz, Waqar Ahmad, et al.. (2013). Stable Huh-7 cell lines expressing non-structural proteins of genotype 1a of hepatitis C virus. Journal of Virological Methods. 189(1). 65–69. 5 indexed citations
14.
Asad, Sultan, Bushra Ijaz, Waqar Ahmad, et al.. (2012). Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell. Virology Journal. 9(1). 11–11. 16 indexed citations
15.
Jahan, Shah, Saba Khaliq, Bushra Ijaz, et al.. (2011). Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell line. Virology Journal. 8(1). 522–522. 14 indexed citations
16.
Ijaz, Bushra, Waqar Ahmad, Muhammad Tahir Sarwar, et al.. (2011). Association of laboratory parameters with viral factors in patients with hepatitis C. Virology Journal. 8(1). 361–361. 24 indexed citations
17.
Kausar, Humera, Bushra Ijaz, Waqar Ahmad, et al.. (2011). Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO). Journal of Translational Medicine. 9(1). 186–186. 5 indexed citations
18.
Ahmad, Waqar, Bushra Ijaz, Humera Kausar, et al.. (2011). HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a. Virology Journal. 8(1). 293–293. 12 indexed citations
19.
Khaliq, Saba, Shah Jahan, Bushra Ijaz, et al.. (2010). Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes. Archives of Virology. 156(3). 433–442. 18 indexed citations
20.
Khaliq, Saba, Saba Khaliq, Muzna Zahur, et al.. (2009). RNAi as a new therapeutic strategy against HCV. Biotechnology Advances. 28(1). 27–34. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Satoshi Sobue Breakdown of academic impact, for papers by Muhammad Ashfaq–Khan Breakdown of academic impact, for papers by Humera Kausar Breakdown of academic impact, for papers by Iara Fabrícia Kretzer Breakdown of academic impact, for papers by Yoshitaka Shirasago Breakdown of academic impact, for papers by Xue Zhou Breakdown of academic impact, for papers by Marika Kleman Breakdown of academic impact, for papers by Mengyun Ke Breakdown of academic impact, for papers by Judy S. Mathew Breakdown of academic impact, for papers by Joo‐Youn Lee
Rankless by CCL
2026